Top Healthcare Stocks
Healthcare stocks are higher with the NYSE Healthcare Sector
Index rising 0.5% and shares of healthcare companies in the S&P
500 adding 03% as a group.
In company news, Osiris Therapeutics (
) has more than doubled in price today, currently rising nearly
129% at $24.40 a share after earlier rising to a new 52-week high
of $24.75 after saying its Grafix drug candidate performed well
beyond expectations in clinical testing with diabetic patients.
According to the company, 62% of patients receiving Grafix in
the randomized, multi-center study had complete closure of their
foot ulcers often associated with diabetes compared with only 21%
of the patients treated with standardized care.
During the crossover phase of the trial, patients whose wounds
failed to close after 12 weeks of standard care had an 80% closure
rate when switched to Grafix, which contains living mesenchymal
stem cells applied directly to wounds.
In other sector news,
(+) AVNR, Enters exclusive, multi-year deal with Merck (
) to co-promote MRK's type 2 diabetes therapies. The package is
worth up to $60 mln over the next three years, AVNR said.
(-) MDCO, Discloses plans to sell up to 5.5 mln shares of its
common stock through an underwritten public offering of stock.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.